Life Merck’s Experimental HIV Prevention Pill Could Cost Less Than $5 a Year Strategic angle: Researchers advocate for urgent licensing of generic production to enhance accessibility. editorial-staff Apr 7
Life ‘Most Favored Nation’ Drug Pricing Is An Idea Whose Time Has Come Strategic angle: Exploring the implications and potential benefits of implementing a Most Favored Nation drug pricing model. editorial-staff Apr 7
Life A star scientist showed that better genetics lessons could reduce racism. It was the death knell for his career Strategic angle: Brian Donovan had persuaded high school teachers and education researchers that prejudice might be ended by changing how genetics is taught. editorial-staff Apr 7
Life FDA backs proposals to entice pharma companies to test, make drugs domestically Strategic angle: From tariffs to incentives, the administration wants to push companies to manufacture drugs in the U.S. editorial-staff Apr 7
Life Opinion: How the insurance system quietly undoes recovery from addiction Strategic angle: People who have been stable for years are suddenly re-exposed to risk — not because their disease worsened, but because their coverage did. editorial-staff Apr 7
Life Opinion: STAT+: Former Geisinger CEO: U.S. health systems must replace huge numbers of people with AI Strategic angle: “Health care will become autonomous because the survival of health systems depends upon it,” writes former Geisinger CEO Glenn Steele. editorial-staff Apr 7
Life Research Revealing How the Brain Flushes Waste Named STAT Madness Editors’ Pick Strategic angle: For researcher Maiken Nedergaard, ‘diseases of aging are basically all about dirty brains’ editorial-staff Apr 7
Life University of Michigan wins 2026 STAT Madness for new insights into abdominal aortic aneurysms Strategic angle: The researchers identified a driving force behind the condition, opening up a potential target for new therapies. editorial-staff Apr 7
Life Pharma companies and patient groups seek to exempt orphan drugs from Colorado pricing limits Strategic angle: A bill is moving through the Colorado legislature that would exempt orphan drugs from pricing caps that might be pursued by the state. editorial-staff Apr 6
Life Global Health Funding in the FY 2027 President’s Budget Request Strategic angle: This budget summary provides an analysis of global health funding amounts provided in the President's FY 2027 budget request. editorial-staff Apr 6
Life California's Medicaid Work Requirements Amid Budget Shortfalls Strategic angle: Examining the state's plans to implement work requirements in Medicaid while facing significant budget challenges. editorial-staff Apr 6
Life STAT+: A key Medicare Advantage announcement is due today Strategic angle: Today's announcement will set the tone for how the Trump administration wants to work with private Medicare insurers. editorial-staff Apr 6
Life How a four-month FDA delay forced a small biotech company to close its doors A small biotech company faced a critical setback due to a delayed agreement with the FDA, leading to its closure. editorial-staff Apr 6
Life Stealth biotech Stipple bets on secretive ADCs Strategic angle: How thin science fuels peptide hype, blowback to proposed NIH cuts, and more biotech news from The Readout editorial-staff Apr 6
Life UnitedHealth makes a bet on AI. What does it mean for us? Strategic angle: A hep B trial raises ethical questions, the peptide hype, and more Morning Rounds news editorial-staff Apr 6
Life Neurocrine Biosciences to buy Soleno Therapeutics in $2.9B deal Strategic angle: Neurocrine Biosciences is acquiring Soleno Therapeutics for $2.9 billion, gaining access to a treatment for a rare disease linked to insatiable hunger. editorial-staff Apr 6
Life Opinion: ‘Medical nutrition’ helps keep my son, and many others, healthy. But insurance won’t cover it Strategic angle: Lifelong disorders require lifelong treatments. editorial-staff Apr 6
Life Opinion: When my child is in psychosis, the pediatric health care system can’t help us Strategic angle: “There is no off switch when the crisis is your child,” writes Liz Koch. editorial-staff Apr 6
Life Briefing: UnitedHealth Group is making a $3 billion bet on AI. What does it mean for patients? Strategic angle: UnitedHealth Group is rapidly deploying artificial intelligence tools across its operations. What does it mean for patients? editorial-staff Apr 6
Life What the peptide craze reveals about Americans’ relationship with risk Strategic angle: Why do RFK Jr. and other health influencers embrace unproven peptides while calling for more research into well-studied vaccines? editorial-staff Apr 6